nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A3—Progesterone—uterine cancer	0.188	0.255	CbGbCtD
Clonidine—SLC22A1—Progesterone—uterine cancer	0.0968	0.131	CbGbCtD
Clonidine—SLC22A5—Dactinomycin—uterine cancer	0.0927	0.125	CbGbCtD
Clonidine—CYP1A1—Progesterone—uterine cancer	0.0759	0.103	CbGbCtD
Clonidine—CYP3A5—Progesterone—uterine cancer	0.0456	0.0617	CbGbCtD
Clonidine—CYP1A2—Progesterone—uterine cancer	0.0339	0.0459	CbGbCtD
Clonidine—ABCB1—Progesterone—uterine cancer	0.0297	0.0401	CbGbCtD
Clonidine—CYP2D6—Progesterone—uterine cancer	0.0279	0.0378	CbGbCtD
Clonidine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0268	0.0363	CbGbCtD
Clonidine—ABCB1—Dactinomycin—uterine cancer	0.0235	0.0318	CbGbCtD
Clonidine—CYP3A5—Etoposide—uterine cancer	0.0204	0.0276	CbGbCtD
Clonidine—CYP3A4—Progesterone—uterine cancer	0.0178	0.024	CbGbCtD
Clonidine—CYP1A2—Etoposide—uterine cancer	0.0152	0.0205	CbGbCtD
Clonidine—ABCB1—Etoposide—uterine cancer	0.0133	0.018	CbGbCtD
Clonidine—ABCB1—Doxorubicin—uterine cancer	0.00905	0.0123	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—uterine cancer	0.00853	0.0115	CbGbCtD
Clonidine—CYP3A4—Etoposide—uterine cancer	0.00795	0.0108	CbGbCtD
Clonidine—CYP3A4—Doxorubicin—uterine cancer	0.00542	0.00734	CbGbCtD
Clonidine—NISCH—Podofilox—Etoposide—uterine cancer	0.00388	1	CbGdCrCtD
Clonidine—NISCH—uterine cervix—uterine cancer	0.00187	0.026	CbGeAlD
Clonidine—NISCH—smooth muscle tissue—uterine cancer	0.00182	0.0253	CbGeAlD
Clonidine—NISCH—decidua—uterine cancer	0.00178	0.0248	CbGeAlD
Clonidine—NISCH—mammalian vulva—uterine cancer	0.00164	0.0228	CbGeAlD
Clonidine—SLC22A4—myometrium—uterine cancer	0.00159	0.0221	CbGeAlD
Clonidine—ADRA1D—epithelium—uterine cancer	0.00158	0.0219	CbGeAlD
Clonidine—NISCH—uterus—uterine cancer	0.00156	0.0217	CbGeAlD
Clonidine—ADRA1B—renal system—uterine cancer	0.00149	0.0208	CbGeAlD
Clonidine—SLC22A3—myometrium—uterine cancer	0.00145	0.0201	CbGeAlD
Clonidine—NISCH—female gonad—uterine cancer	0.00128	0.0178	CbGeAlD
Clonidine—NISCH—vagina—uterine cancer	0.00127	0.0176	CbGeAlD
Clonidine—Diclofenac—CXCL8—uterine cancer	0.00119	1	CrCbGaD
Clonidine—SLC22A4—decidua—uterine cancer	0.00118	0.0164	CbGeAlD
Clonidine—ADRA1D—female reproductive system—uterine cancer	0.00117	0.0163	CbGeAlD
Clonidine—SLC22A4—renal system—uterine cancer	0.00116	0.0161	CbGeAlD
Clonidine—SLC22A3—uterine cervix—uterine cancer	0.00113	0.0157	CbGeAlD
Clonidine—SLC22A4—endometrium—uterine cancer	0.00112	0.0156	CbGeAlD
Clonidine—SLC22A1—renal system—uterine cancer	0.0011	0.0153	CbGeAlD
Clonidine—ADRA2C—myometrium—uterine cancer	0.0011	0.0153	CbGeAlD
Clonidine—SLC22A3—smooth muscle tissue—uterine cancer	0.0011	0.0152	CbGeAlD
Clonidine—SLC22A3—renal system—uterine cancer	0.00105	0.0147	CbGeAlD
Clonidine—SLC22A5—myometrium—uterine cancer	0.00105	0.0146	CbGeAlD
Clonidine—SLC22A3—endometrium—uterine cancer	0.00102	0.0142	CbGeAlD
Clonidine—SLC22A3—mammalian vulva—uterine cancer	0.000986	0.0137	CbGeAlD
Clonidine—SLC22A4—female reproductive system—uterine cancer	0.000928	0.0129	CbGeAlD
Clonidine—SLC6A2—decidua—uterine cancer	0.00092	0.0128	CbGeAlD
Clonidine—ADRA1A—epithelium—uterine cancer	0.000905	0.0126	CbGeAlD
Clonidine—ADRA2A—myometrium—uterine cancer	0.000877	0.0122	CbGeAlD
Clonidine—ADRA2C—uterine cervix—uterine cancer	0.000855	0.0119	CbGeAlD
Clonidine—SLC22A3—female reproductive system—uterine cancer	0.000844	0.0117	CbGeAlD
Clonidine—ADRA1A—renal system—uterine cancer	0.00084	0.0117	CbGeAlD
Clonidine—SLC22A4—vagina—uterine cancer	0.000839	0.0117	CbGeAlD
Clonidine—NISCH—lymph node—uterine cancer	0.000821	0.0114	CbGeAlD
Clonidine—SLC22A5—uterine cervix—uterine cancer	0.000819	0.0114	CbGeAlD
Clonidine—ADRA2C—decidua—uterine cancer	0.000815	0.0113	CbGeAlD
Clonidine—ADRA2C—renal system—uterine cancer	0.0008	0.0111	CbGeAlD
Clonidine—SLC22A1—vagina—uterine cancer	0.000799	0.0111	CbGeAlD
Clonidine—ADRA2C—endometrium—uterine cancer	0.000774	0.0108	CbGeAlD
Clonidine—SLC22A3—female gonad—uterine cancer	0.000768	0.0107	CbGeAlD
Clonidine—SLC22A5—renal system—uterine cancer	0.000767	0.0107	CbGeAlD
Clonidine—SLC22A3—vagina—uterine cancer	0.000764	0.0106	CbGeAlD
Clonidine—ADRA2C—mammalian vulva—uterine cancer	0.000748	0.0104	CbGeAlD
Clonidine—SLC22A5—endometrium—uterine cancer	0.000741	0.0103	CbGeAlD
Clonidine—CYP1A1—epithelium—uterine cancer	0.000739	0.0103	CbGeAlD
Clonidine—CYP1A1—uterine cervix—uterine cancer	0.000732	0.0102	CbGeAlD
Clonidine—SLC6A2—female reproductive system—uterine cancer	0.000724	0.0101	CbGeAlD
Clonidine—CYP3A5—uterine cervix—uterine cancer	0.000716	0.00996	CbGeAlD
Clonidine—ADRA2C—uterus—uterine cancer	0.000713	0.00991	CbGeAlD
Clonidine—CYP1A2—renal system—uterine cancer	0.000694	0.00966	CbGeAlD
Clonidine—CYP1A1—renal system—uterine cancer	0.000685	0.00952	CbGeAlD
Clonidine—ADRA2A—uterine cervix—uterine cancer	0.000683	0.00949	CbGeAlD
Clonidine—CYP3A5—renal system—uterine cancer	0.00067	0.00931	CbGeAlD
Clonidine—ADRA2A—decidua—uterine cancer	0.00065	0.00904	CbGeAlD
Clonidine—CYP1A1—mammalian vulva—uterine cancer	0.000641	0.00891	CbGeAlD
Clonidine—ADRA2A—endometrium—uterine cancer	0.000617	0.00858	CbGeAlD
Clonidine—SLC22A5—female reproductive system—uterine cancer	0.000614	0.00854	CbGeAlD
Clonidine—CYP1A1—uterus—uterine cancer	0.00061	0.00849	CbGeAlD
Clonidine—ADRA2A—mammalian vulva—uterine cancer	0.000597	0.0083	CbGeAlD
Clonidine—ADRA2C—female gonad—uterine cancer	0.000583	0.00811	CbGeAlD
Clonidine—ADRA2C—vagina—uterine cancer	0.00058	0.00806	CbGeAlD
Clonidine—ADRA2A—uterus—uterine cancer	0.000569	0.00791	CbGeAlD
Clonidine—SLC22A5—female gonad—uterine cancer	0.000559	0.00777	CbGeAlD
Clonidine—SLC22A5—vagina—uterine cancer	0.000555	0.00772	CbGeAlD
Clonidine—CYP1A1—female reproductive system—uterine cancer	0.000549	0.00763	CbGeAlD
Clonidine—SLC22A4—lymph node—uterine cancer	0.000543	0.00755	CbGeAlD
Clonidine—ADRA2A—female reproductive system—uterine cancer	0.000511	0.00711	CbGeAlD
Clonidine—CYP3A4—renal system—uterine cancer	0.000503	0.00699	CbGeAlD
Clonidine—CYP1A1—female gonad—uterine cancer	0.000499	0.00694	CbGeAlD
Clonidine—CYP1A1—vagina—uterine cancer	0.000496	0.0069	CbGeAlD
Clonidine—CYP2D6—renal system—uterine cancer	0.000495	0.00688	CbGeAlD
Clonidine—SLC22A3—lymph node—uterine cancer	0.000494	0.00687	CbGeAlD
Clonidine—ABCB1—myometrium—uterine cancer	0.000489	0.0068	CbGeAlD
Clonidine—CYP3A5—female gonad—uterine cancer	0.000488	0.00679	CbGeAlD
Clonidine—CYP3A5—vagina—uterine cancer	0.000485	0.00675	CbGeAlD
Clonidine—ADRA2A—female gonad—uterine cancer	0.000465	0.00647	CbGeAlD
Clonidine—ADRA2A—vagina—uterine cancer	0.000463	0.00643	CbGeAlD
Clonidine—SLC6A2—lymph node—uterine cancer	0.000423	0.00588	CbGeAlD
Clonidine—CYP3A4—female reproductive system—uterine cancer	0.000403	0.0056	CbGeAlD
Clonidine—CYP2D6—female reproductive system—uterine cancer	0.000396	0.00551	CbGeAlD
Clonidine—ABCB1—epithelium—uterine cancer	0.000384	0.00533	CbGeAlD
Clonidine—ABCB1—uterine cervix—uterine cancer	0.00038	0.00529	CbGeAlD
Clonidine—ADRA2C—lymph node—uterine cancer	0.000375	0.00521	CbGeAlD
Clonidine—ABCB1—decidua—uterine cancer	0.000362	0.00504	CbGeAlD
Clonidine—CYP2D6—female gonad—uterine cancer	0.00036	0.00501	CbGeAlD
Clonidine—SLC22A5—lymph node—uterine cancer	0.000359	0.00499	CbGeAlD
Clonidine—ABCB1—renal system—uterine cancer	0.000356	0.00495	CbGeAlD
Clonidine—ABCB1—endometrium—uterine cancer	0.000344	0.00478	CbGeAlD
Clonidine—ABCB1—mammalian vulva—uterine cancer	0.000333	0.00463	CbGeAlD
Clonidine—Oedema—Dactinomycin—uterine cancer	0.000325	0.00177	CcSEcCtD
Clonidine—Infection—Dactinomycin—uterine cancer	0.000322	0.00176	CcSEcCtD
Clonidine—CYP1A1—lymph node—uterine cancer	0.000321	0.00446	CbGeAlD
Clonidine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000318	0.00173	CcSEcCtD
Clonidine—ABCB1—uterus—uterine cancer	0.000317	0.00441	CbGeAlD
Clonidine—Dry eye—Doxorubicin—uterine cancer	0.000315	0.00172	CcSEcCtD
Clonidine—Diarrhoea—Progesterone—uterine cancer	0.000314	0.00171	CcSEcCtD
Clonidine—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000314	0.00171	CcSEcCtD
Clonidine—Rash maculo-papular—Doxorubicin—uterine cancer	0.00031	0.00169	CcSEcCtD
Clonidine—Anorexia—Dactinomycin—uterine cancer	0.000309	0.00169	CcSEcCtD
Clonidine—Eye disorder—Etoposide—uterine cancer	0.000309	0.00169	CcSEcCtD
Clonidine—Cardiac disorder—Etoposide—uterine cancer	0.000307	0.00167	CcSEcCtD
Clonidine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000307	0.00167	CcSEcCtD
Clonidine—Dizziness—Progesterone—uterine cancer	0.000304	0.00166	CcSEcCtD
Clonidine—Angiopathy—Etoposide—uterine cancer	0.0003	0.00164	CcSEcCtD
Clonidine—ADRA2A—lymph node—uterine cancer	0.000299	0.00416	CbGeAlD
Clonidine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000298	0.00163	CcSEcCtD
Clonidine—Mediastinal disorder—Etoposide—uterine cancer	0.000298	0.00163	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000296	0.00161	CcSEcCtD
Clonidine—Cardiac failure congestive—Epirubicin—uterine cancer	0.000295	0.00161	CcSEcCtD
Clonidine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000294	0.00161	CcSEcCtD
Clonidine—Alopecia—Etoposide—uterine cancer	0.000292	0.00159	CcSEcCtD
Clonidine—Vomiting—Progesterone—uterine cancer	0.000292	0.00159	CcSEcCtD
Clonidine—Rash—Progesterone—uterine cancer	0.000289	0.00158	CcSEcCtD
Clonidine—Dermatitis—Progesterone—uterine cancer	0.000289	0.00158	CcSEcCtD
Clonidine—Headache—Progesterone—uterine cancer	0.000288	0.00157	CcSEcCtD
Clonidine—ABCB1—female reproductive system—uterine cancer	0.000285	0.00396	CbGeAlD
Clonidine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.00155	CcSEcCtD
Clonidine—Decreased appetite—Dactinomycin—uterine cancer	0.000282	0.00154	CcSEcCtD
Clonidine—Fatigue—Dactinomycin—uterine cancer	0.00028	0.00153	CcSEcCtD
Clonidine—Pain—Dactinomycin—uterine cancer	0.000278	0.00151	CcSEcCtD
Clonidine—Muscle spasms—Etoposide—uterine cancer	0.000277	0.00151	CcSEcCtD
Clonidine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000275	0.0015	CcSEcCtD
Clonidine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000273	0.00149	CcSEcCtD
Clonidine—Lethargy—Epirubicin—uterine cancer	0.000273	0.00149	CcSEcCtD
Clonidine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000273	0.00149	CcSEcCtD
Clonidine—Nausea—Progesterone—uterine cancer	0.000273	0.00149	CcSEcCtD
Clonidine—Pain in extremity—Epirubicin—uterine cancer	0.000268	0.00146	CcSEcCtD
Clonidine—Feeling abnormal—Dactinomycin—uterine cancer	0.000267	0.00146	CcSEcCtD
Clonidine—Ill-defined disorder—Etoposide—uterine cancer	0.000267	0.00146	CcSEcCtD
Clonidine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000265	0.00145	CcSEcCtD
Clonidine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000265	0.00144	CcSEcCtD
Clonidine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000262	0.00143	CcSEcCtD
Clonidine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000262	0.00143	CcSEcCtD
Clonidine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000261	0.00142	CcSEcCtD
Clonidine—Malaise—Etoposide—uterine cancer	0.00026	0.00142	CcSEcCtD
Clonidine—ABCB1—female gonad—uterine cancer	0.000259	0.00361	CbGeAlD
Clonidine—ABCB1—vagina—uterine cancer	0.000258	0.00358	CbGeAlD
Clonidine—Abdominal pain—Dactinomycin—uterine cancer	0.000257	0.0014	CcSEcCtD
Clonidine—Body temperature increased—Dactinomycin—uterine cancer	0.000257	0.0014	CcSEcCtD
Clonidine—Loss of consciousness—Etoposide—uterine cancer	0.000253	0.00138	CcSEcCtD
Clonidine—Lethargy—Doxorubicin—uterine cancer	0.000253	0.00138	CcSEcCtD
Clonidine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000253	0.00138	CcSEcCtD
Clonidine—Cough—Etoposide—uterine cancer	0.000251	0.00137	CcSEcCtD
Clonidine—Pain in extremity—Doxorubicin—uterine cancer	0.000248	0.00135	CcSEcCtD
Clonidine—Liver function test abnormal—Epirubicin—uterine cancer	0.000247	0.00135	CcSEcCtD
Clonidine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000247	0.00135	CcSEcCtD
Clonidine—Chest pain—Etoposide—uterine cancer	0.000245	0.00134	CcSEcCtD
Clonidine—Abdominal pain upper—Epirubicin—uterine cancer	0.000245	0.00133	CcSEcCtD
Clonidine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000245	0.00133	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000243	0.00133	CcSEcCtD
Clonidine—Discomfort—Etoposide—uterine cancer	0.000242	0.00132	CcSEcCtD
Clonidine—Breast disorder—Epirubicin—uterine cancer	0.000242	0.00132	CcSEcCtD
Clonidine—Nasopharyngitis—Epirubicin—uterine cancer	0.00024	0.00131	CcSEcCtD
Clonidine—Hypersensitivity—Dactinomycin—uterine cancer	0.000239	0.0013	CcSEcCtD
Clonidine—Confusional state—Etoposide—uterine cancer	0.000237	0.00129	CcSEcCtD
Clonidine—Infection—Etoposide—uterine cancer	0.000233	0.00127	CcSEcCtD
Clonidine—Asthenia—Dactinomycin—uterine cancer	0.000233	0.00127	CcSEcCtD
Clonidine—Asthma—Epirubicin—uterine cancer	0.000232	0.00126	CcSEcCtD
Clonidine—Thrombocytopenia—Etoposide—uterine cancer	0.00023	0.00125	CcSEcCtD
Clonidine—Tachycardia—Etoposide—uterine cancer	0.000229	0.00125	CcSEcCtD
Clonidine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000229	0.00125	CcSEcCtD
Clonidine—Skin disorder—Etoposide—uterine cancer	0.000228	0.00124	CcSEcCtD
Clonidine—Hyperhidrosis—Etoposide—uterine cancer	0.000227	0.00124	CcSEcCtD
Clonidine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000226	0.00123	CcSEcCtD
Clonidine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000226	0.00123	CcSEcCtD
Clonidine—Breast disorder—Doxorubicin—uterine cancer	0.000224	0.00122	CcSEcCtD
Clonidine—Anorexia—Etoposide—uterine cancer	0.000224	0.00122	CcSEcCtD
Clonidine—Diarrhoea—Dactinomycin—uterine cancer	0.000222	0.00121	CcSEcCtD
Clonidine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000222	0.00121	CcSEcCtD
Clonidine—Hypotension—Etoposide—uterine cancer	0.000219	0.0012	CcSEcCtD
Clonidine—Dysuria—Epirubicin—uterine cancer	0.000216	0.00118	CcSEcCtD
Clonidine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000215	0.00117	CcSEcCtD
Clonidine—Asthma—Doxorubicin—uterine cancer	0.000214	0.00117	CcSEcCtD
Clonidine—Pollakiuria—Epirubicin—uterine cancer	0.000214	0.00117	CcSEcCtD
Clonidine—Paraesthesia—Etoposide—uterine cancer	0.000211	0.00115	CcSEcCtD
Clonidine—Weight increased—Epirubicin—uterine cancer	0.000211	0.00115	CcSEcCtD
Clonidine—Dyspnoea—Etoposide—uterine cancer	0.000209	0.00114	CcSEcCtD
Clonidine—Somnolence—Etoposide—uterine cancer	0.000209	0.00114	CcSEcCtD
Clonidine—Drowsiness—Epirubicin—uterine cancer	0.000206	0.00113	CcSEcCtD
Clonidine—Vomiting—Dactinomycin—uterine cancer	0.000206	0.00113	CcSEcCtD
Clonidine—Rash—Dactinomycin—uterine cancer	0.000205	0.00112	CcSEcCtD
Clonidine—Decreased appetite—Etoposide—uterine cancer	0.000204	0.00111	CcSEcCtD
Clonidine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000203	0.00111	CcSEcCtD
Clonidine—Fatigue—Etoposide—uterine cancer	0.000202	0.0011	CcSEcCtD
Clonidine—Pain—Etoposide—uterine cancer	0.000201	0.0011	CcSEcCtD
Clonidine—Constipation—Etoposide—uterine cancer	0.000201	0.0011	CcSEcCtD
Clonidine—Urinary tract infection—Epirubicin—uterine cancer	0.000201	0.00109	CcSEcCtD
Clonidine—Dysuria—Doxorubicin—uterine cancer	0.0002	0.00109	CcSEcCtD
Clonidine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000199	0.00109	CcSEcCtD
Clonidine—Sweating—Epirubicin—uterine cancer	0.000198	0.00108	CcSEcCtD
Clonidine—Pollakiuria—Doxorubicin—uterine cancer	0.000198	0.00108	CcSEcCtD
Clonidine—Weight increased—Doxorubicin—uterine cancer	0.000195	0.00106	CcSEcCtD
Clonidine—Epistaxis—Epirubicin—uterine cancer	0.000195	0.00106	CcSEcCtD
Clonidine—Feeling abnormal—Etoposide—uterine cancer	0.000194	0.00106	CcSEcCtD
Clonidine—Nausea—Dactinomycin—uterine cancer	0.000193	0.00105	CcSEcCtD
Clonidine—Gastrointestinal pain—Etoposide—uterine cancer	0.000192	0.00105	CcSEcCtD
Clonidine—Drowsiness—Doxorubicin—uterine cancer	0.000191	0.00104	CcSEcCtD
Clonidine—Bradycardia—Epirubicin—uterine cancer	0.000189	0.00103	CcSEcCtD
Clonidine—Urticaria—Etoposide—uterine cancer	0.000187	0.00102	CcSEcCtD
Clonidine—Rhinitis—Epirubicin—uterine cancer	0.000186	0.00101	CcSEcCtD
Clonidine—Abdominal pain—Etoposide—uterine cancer	0.000186	0.00101	CcSEcCtD
Clonidine—Body temperature increased—Etoposide—uterine cancer	0.000186	0.00101	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—uterine cancer	0.000186	0.00101	CcSEcCtD
Clonidine—Hepatitis—Epirubicin—uterine cancer	0.000185	0.00101	CcSEcCtD
Clonidine—Hypoaesthesia—Epirubicin—uterine cancer	0.000184	0.00101	CcSEcCtD
Clonidine—Sweating—Doxorubicin—uterine cancer	0.000183	0.000999	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—uterine cancer	0.00018	0.000983	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—uterine cancer	0.000175	0.000952	CcSEcCtD
Clonidine—Eye disorder—Epirubicin—uterine cancer	0.000173	0.000945	CcSEcCtD
Clonidine—Hypersensitivity—Etoposide—uterine cancer	0.000173	0.000944	CcSEcCtD
Clonidine—Tinnitus—Epirubicin—uterine cancer	0.000173	0.000942	CcSEcCtD
Clonidine—Cardiac disorder—Epirubicin—uterine cancer	0.000172	0.000938	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—uterine cancer	0.000172	0.000938	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—uterine cancer	0.000171	0.000935	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000171	0.000931	CcSEcCtD
Clonidine—Asthenia—Etoposide—uterine cancer	0.000169	0.000919	CcSEcCtD
Clonidine—Angiopathy—Epirubicin—uterine cancer	0.000168	0.000917	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—uterine cancer	0.000167	0.000911	CcSEcCtD
Clonidine—ABCB1—lymph node—uterine cancer	0.000167	0.00232	CbGeAlD
Clonidine—Pruritus—Etoposide—uterine cancer	0.000166	0.000906	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—uterine cancer	0.000166	0.000903	CcSEcCtD
Clonidine—Alopecia—Epirubicin—uterine cancer	0.000164	0.000893	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—uterine cancer	0.000162	0.000886	CcSEcCtD
Clonidine—Erythema—Epirubicin—uterine cancer	0.000161	0.00088	CcSEcCtD
Clonidine—Diarrhoea—Etoposide—uterine cancer	0.000161	0.000877	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—uterine cancer	0.00016	0.000874	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—uterine cancer	0.00016	0.000872	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—uterine cancer	0.000159	0.000868	CcSEcCtD
Clonidine—Tension—Epirubicin—uterine cancer	0.000158	0.000863	CcSEcCtD
Clonidine—Nervousness—Epirubicin—uterine cancer	0.000157	0.000855	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—uterine cancer	0.000156	0.000849	CcSEcCtD
Clonidine—Dizziness—Etoposide—uterine cancer	0.000155	0.000847	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—uterine cancer	0.000155	0.000846	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000155	0.000843	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—uterine cancer	0.000153	0.000836	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—uterine cancer	0.000152	0.000829	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—uterine cancer	0.000152	0.000826	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—uterine cancer	0.00015	0.000819	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—uterine cancer	0.00015	0.000816	CcSEcCtD
Clonidine—Vomiting—Etoposide—uterine cancer	0.000149	0.000815	CcSEcCtD
Clonidine—Erythema—Doxorubicin—uterine cancer	0.000149	0.000814	CcSEcCtD
Clonidine—Agitation—Epirubicin—uterine cancer	0.000148	0.000809	CcSEcCtD
Clonidine—Rash—Etoposide—uterine cancer	0.000148	0.000808	CcSEcCtD
Clonidine—Dermatitis—Etoposide—uterine cancer	0.000148	0.000807	CcSEcCtD
Clonidine—Headache—Etoposide—uterine cancer	0.000147	0.000803	CcSEcCtD
Clonidine—Tension—Doxorubicin—uterine cancer	0.000146	0.000799	CcSEcCtD
Clonidine—Malaise—Epirubicin—uterine cancer	0.000145	0.000793	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—uterine cancer	0.000145	0.000791	CcSEcCtD
Clonidine—Syncope—Epirubicin—uterine cancer	0.000145	0.000789	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—uterine cancer	0.000144	0.000783	CcSEcCtD
Clonidine—Palpitations—Epirubicin—uterine cancer	0.000143	0.000778	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—uterine cancer	0.000142	0.000773	CcSEcCtD
Clonidine—Cough—Epirubicin—uterine cancer	0.000141	0.000768	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—uterine cancer	0.000141	0.000767	CcSEcCtD
Clonidine—Nausea—Etoposide—uterine cancer	0.00014	0.000761	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000138	0.000755	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—uterine cancer	0.000137	0.000749	CcSEcCtD
Clonidine—Chest pain—Epirubicin—uterine cancer	0.000137	0.000749	CcSEcCtD
Clonidine—Agitation—Doxorubicin—uterine cancer	0.000137	0.000748	CcSEcCtD
Clonidine—Anxiety—Epirubicin—uterine cancer	0.000137	0.000747	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000136	0.000744	CcSEcCtD
Clonidine—Discomfort—Epirubicin—uterine cancer	0.000136	0.00074	CcSEcCtD
Clonidine—Malaise—Doxorubicin—uterine cancer	0.000135	0.000734	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—uterine cancer	0.000134	0.000733	CcSEcCtD
Clonidine—Syncope—Doxorubicin—uterine cancer	0.000134	0.00073	CcSEcCtD
Clonidine—Confusional state—Epirubicin—uterine cancer	0.000133	0.000724	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—uterine cancer	0.000132	0.000719	CcSEcCtD
Clonidine—Oedema—Epirubicin—uterine cancer	0.000132	0.000718	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—uterine cancer	0.000131	0.000716	CcSEcCtD
Clonidine—Infection—Epirubicin—uterine cancer	0.000131	0.000713	CcSEcCtD
Clonidine—Cough—Doxorubicin—uterine cancer	0.00013	0.00071	CcSEcCtD
Clonidine—Shock—Epirubicin—uterine cancer	0.00013	0.000707	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—uterine cancer	0.000129	0.000704	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—uterine cancer	0.000129	0.000703	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—uterine cancer	0.000128	0.000701	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—uterine cancer	0.000128	0.000698	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—uterine cancer	0.000127	0.000694	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—uterine cancer	0.000127	0.000693	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—uterine cancer	0.000127	0.000693	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—uterine cancer	0.000127	0.000691	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000126	0.000688	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—uterine cancer	0.000126	0.000685	CcSEcCtD
Clonidine—Anorexia—Epirubicin—uterine cancer	0.000125	0.000685	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—uterine cancer	0.000124	0.000678	CcSEcCtD
Clonidine—Hypotension—Epirubicin—uterine cancer	0.000123	0.000671	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—uterine cancer	0.000123	0.00067	CcSEcCtD
Clonidine—Oedema—Doxorubicin—uterine cancer	0.000122	0.000664	CcSEcCtD
Clonidine—Infection—Doxorubicin—uterine cancer	0.000121	0.00066	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00012	0.000654	CcSEcCtD
Clonidine—Shock—Doxorubicin—uterine cancer	0.00012	0.000654	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—uterine cancer	0.000119	0.000652	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000119	0.000651	CcSEcCtD
Clonidine—Insomnia—Epirubicin—uterine cancer	0.000119	0.00065	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—uterine cancer	0.000119	0.000649	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—uterine cancer	0.000118	0.000645	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—uterine cancer	0.000118	0.000645	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000118	0.000642	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—uterine cancer	0.000117	0.00064	CcSEcCtD
Clonidine—Somnolence—Epirubicin—uterine cancer	0.000117	0.000638	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—uterine cancer	0.000116	0.000633	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—uterine cancer	0.000114	0.000624	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—uterine cancer	0.000114	0.000621	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000114	0.00062	CcSEcCtD
Clonidine—Fatigue—Epirubicin—uterine cancer	0.000114	0.000619	CcSEcCtD
Clonidine—Pain—Epirubicin—uterine cancer	0.000113	0.000614	CcSEcCtD
Clonidine—Constipation—Epirubicin—uterine cancer	0.000113	0.000614	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000111	0.000605	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—uterine cancer	0.00011	0.000601	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—uterine cancer	0.000109	0.000597	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—uterine cancer	0.000109	0.000592	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—uterine cancer	0.000108	0.000592	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—uterine cancer	0.000108	0.000591	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000108	0.000587	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—uterine cancer	0.000106	0.000578	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000105	0.000574	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—uterine cancer	0.000105	0.000573	CcSEcCtD
Clonidine—Urticaria—Epirubicin—uterine cancer	0.000105	0.00057	CcSEcCtD
Clonidine—Constipation—Doxorubicin—uterine cancer	0.000104	0.000568	CcSEcCtD
Clonidine—Pain—Doxorubicin—uterine cancer	0.000104	0.000568	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—uterine cancer	0.000104	0.000568	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—uterine cancer	0.000104	0.000568	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—uterine cancer	0.0001	0.000548	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—uterine cancer	9.96e-05	0.000543	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—uterine cancer	9.7e-05	0.000529	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—uterine cancer	9.68e-05	0.000528	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—uterine cancer	9.63e-05	0.000525	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—uterine cancer	9.63e-05	0.000525	CcSEcCtD
Clonidine—Asthenia—Epirubicin—uterine cancer	9.45e-05	0.000515	CcSEcCtD
Clonidine—Pruritus—Epirubicin—uterine cancer	9.31e-05	0.000508	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—uterine cancer	9.01e-05	0.000491	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—uterine cancer	8.98e-05	0.00049	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—uterine cancer	8.74e-05	0.000477	CcSEcCtD
Clonidine—Dizziness—Epirubicin—uterine cancer	8.71e-05	0.000475	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—uterine cancer	8.62e-05	0.00047	CcSEcCtD
Clonidine—Vomiting—Epirubicin—uterine cancer	8.37e-05	0.000457	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—uterine cancer	8.33e-05	0.000455	CcSEcCtD
Clonidine—Rash—Epirubicin—uterine cancer	8.3e-05	0.000453	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—uterine cancer	8.29e-05	0.000452	CcSEcCtD
Clonidine—Headache—Epirubicin—uterine cancer	8.25e-05	0.00045	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—uterine cancer	8.06e-05	0.000439	CcSEcCtD
Clonidine—Nausea—Epirubicin—uterine cancer	7.82e-05	0.000427	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—uterine cancer	7.75e-05	0.000422	CcSEcCtD
Clonidine—Rash—Doxorubicin—uterine cancer	7.68e-05	0.000419	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—uterine cancer	7.67e-05	0.000419	CcSEcCtD
Clonidine—Headache—Doxorubicin—uterine cancer	7.63e-05	0.000416	CcSEcCtD
Clonidine—Nausea—Doxorubicin—uterine cancer	7.24e-05	0.000395	CcSEcCtD
Clonidine—ADRA2C—Signaling Pathways—IGF1R—uterine cancer	3.15e-07	0.000428	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.15e-07	0.000428	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—CCL2—uterine cancer	3.15e-07	0.000428	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—PIK3CA—uterine cancer	3.15e-07	0.000428	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—CXCL8—uterine cancer	3.14e-07	0.000426	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKR1C3—uterine cancer	3.12e-07	0.000424	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—HRAS—uterine cancer	3.12e-07	0.000424	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—MTHFR—uterine cancer	3.12e-07	0.000424	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP11A1—uterine cancer	3.11e-07	0.000423	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IGF1R—uterine cancer	3.1e-07	0.000422	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—CXCL8—uterine cancer	3.09e-07	0.00042	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—CXCL8—uterine cancer	3.05e-07	0.000415	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—uterine cancer	3.05e-07	0.000414	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—STK11—uterine cancer	3.04e-07	0.000414	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CYP19A1—uterine cancer	3.04e-07	0.000414	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—FGFR2—uterine cancer	3.02e-07	0.000411	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PTEN—uterine cancer	2.97e-07	0.000403	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SOCS3—uterine cancer	2.96e-07	0.000403	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SMAD3—uterine cancer	2.96e-07	0.000403	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.94e-07	0.0004	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STK11—uterine cancer	2.94e-07	0.0004	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CCL2—uterine cancer	2.93e-07	0.000398	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SMAD3—uterine cancer	2.91e-07	0.000396	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—HRAS—uterine cancer	2.91e-07	0.000396	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—RRM2—uterine cancer	2.88e-07	0.000392	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—ESR1—uterine cancer	2.87e-07	0.00039	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.86e-07	0.000388	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—CXCL8—uterine cancer	2.85e-07	0.000387	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN2B—uterine cancer	2.84e-07	0.000386	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—EP300—uterine cancer	2.83e-07	0.000385	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—FGFR2—uterine cancer	2.82e-07	0.000384	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—CXCL8—uterine cancer	2.8e-07	0.000381	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—DCN—uterine cancer	2.8e-07	0.000381	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—KRAS—uterine cancer	2.78e-07	0.000378	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—FGFR2—uterine cancer	2.78e-07	0.000378	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IGF1R—uterine cancer	2.75e-07	0.000374	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—AKT1—uterine cancer	2.75e-07	0.000374	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SOCS3—uterine cancer	2.75e-07	0.000374	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—CXCL8—uterine cancer	2.74e-07	0.000373	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.72e-07	0.00037	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—NRAS—uterine cancer	2.71e-07	0.000368	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—POLD1—uterine cancer	2.67e-07	0.000363	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—MTHFR—uterine cancer	2.64e-07	0.000359	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP11A1—uterine cancer	2.64e-07	0.000359	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN2B—uterine cancer	2.63e-07	0.000358	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SMAD3—uterine cancer	2.59e-07	0.000352	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ESR1—uterine cancer	2.59e-07	0.000352	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—AKT1—uterine cancer	2.57e-07	0.00035	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IGF1R—uterine cancer	2.56e-07	0.000348	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—PIK3CA—uterine cancer	2.56e-07	0.000348	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—CXCL8—uterine cancer	2.55e-07	0.000346	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCL2—uterine cancer	2.52e-07	0.000343	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.5e-07	0.00034	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKR1C3—uterine cancer	2.49e-07	0.000339	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—CXCL8—uterine cancer	2.49e-07	0.000339	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—uterine cancer	2.47e-07	0.000336	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FGFR2—uterine cancer	2.47e-07	0.000336	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—NRAS—uterine cancer	2.45e-07	0.000333	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—STK11—uterine cancer	2.43e-07	0.000331	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP19A1—uterine cancer	2.43e-07	0.000331	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—MTHFR—uterine cancer	2.42e-07	0.000329	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ESR1—uterine cancer	2.42e-07	0.000329	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SMAD3—uterine cancer	2.41e-07	0.000327	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ESR1—uterine cancer	2.38e-07	0.000323	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—HRAS—uterine cancer	2.37e-07	0.000322	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—PIK3CA—uterine cancer	2.36e-07	0.000321	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—KRAS—uterine cancer	2.33e-07	0.000317	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CXCL8—uterine cancer	2.31e-07	0.000315	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FGFR2—uterine cancer	2.29e-07	0.000312	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—STK11—uterine cancer	2.29e-07	0.000311	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP19A1—uterine cancer	2.29e-07	0.000311	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—MTHFR—uterine cancer	2.29e-07	0.000311	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—NRAS—uterine cancer	2.28e-07	0.000311	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCL2—uterine cancer	2.28e-07	0.00031	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—NRAS—uterine cancer	2.25e-07	0.000306	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—RRM2—uterine cancer	2.23e-07	0.000303	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—DCN—uterine cancer	2.16e-07	0.000294	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—PIK3CA—uterine cancer	2.14e-07	0.000291	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—PIK3CA—uterine cancer	2.13e-07	0.00029	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCL2—uterine cancer	2.13e-07	0.000289	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ESR1—uterine cancer	2.11e-07	0.000287	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—KRAS—uterine cancer	2.11e-07	0.000286	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—ERBB2—uterine cancer	2.1e-07	0.000286	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCL2—uterine cancer	2.09e-07	0.000285	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PIK3CA—uterine cancer	2.09e-07	0.000284	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—AKT1—uterine cancer	2.09e-07	0.000284	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.04e-07	0.000277	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.02e-07	0.000274	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—NRAS—uterine cancer	2e-07	0.000272	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CXCL8—uterine cancer	1.99e-07	0.000271	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—PIK3CA—uterine cancer	1.99e-07	0.000271	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—HRAS—uterine cancer	1.98e-07	0.00027	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—KRAS—uterine cancer	1.97e-07	0.000267	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ESR1—uterine cancer	1.96e-07	0.000267	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—PIK3CA—uterine cancer	1.96e-07	0.000266	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CDKN1B—uterine cancer	1.95e-07	0.000265	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.94e-07	0.000264	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—STK11—uterine cancer	1.94e-07	0.000264	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—KRAS—uterine cancer	1.94e-07	0.000263	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PIK3CA—uterine cancer	1.93e-07	0.000263	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKT1—uterine cancer	1.93e-07	0.000262	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.92e-07	0.000261	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ERBB2—uterine cancer	1.9e-07	0.000258	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCL2—uterine cancer	1.86e-07	0.000253	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—NRAS—uterine cancer	1.86e-07	0.000252	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CTNNB1—uterine cancer	1.84e-07	0.00025	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—MTHFR—uterine cancer	1.83e-07	0.000248	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.82e-07	0.000248	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTEN—uterine cancer	1.81e-07	0.000246	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PIK3CA—uterine cancer	1.81e-07	0.000246	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CXCL8—uterine cancer	1.8e-07	0.000245	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PTEN—uterine cancer	1.79e-07	0.000244	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HRAS—uterine cancer	1.79e-07	0.000243	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PIK3CA—uterine cancer	1.78e-07	0.000242	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB2—uterine cancer	1.77e-07	0.000241	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1B—uterine cancer	1.76e-07	0.000239	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—uterine cancer	1.75e-07	0.000238	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB2—uterine cancer	1.75e-07	0.000237	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—uterine cancer	1.74e-07	0.000237	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	1.74e-07	0.000236	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.74e-07	0.000236	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTEN—uterine cancer	1.73e-07	0.000236	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCL2—uterine cancer	1.73e-07	0.000235	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—EP300—uterine cancer	1.73e-07	0.000235	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—MTHFR—uterine cancer	1.72e-07	0.000234	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	1.72e-07	0.000234	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EP300—uterine cancer	1.71e-07	0.000233	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—uterine cancer	1.71e-07	0.000232	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—uterine cancer	1.68e-07	0.000229	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—uterine cancer	1.67e-07	0.000227	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CTNNB1—uterine cancer	1.66e-07	0.000226	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	1.66e-07	0.000225	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—EP300—uterine cancer	1.65e-07	0.000225	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	1.64e-07	0.000224	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1B—uterine cancer	1.64e-07	0.000223	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—uterine cancer	1.63e-07	0.000221	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—uterine cancer	1.62e-07	0.00022	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—uterine cancer	1.62e-07	0.00022	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	1.62e-07	0.00022	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	1.62e-07	0.00022	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRAS—uterine cancer	1.6e-07	0.000218	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	1.6e-07	0.000217	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	1.6e-07	0.000217	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—uterine cancer	1.58e-07	0.000215	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	1.58e-07	0.000215	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	1.55e-07	0.000211	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	1.55e-07	0.000211	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EP300—uterine cancer	1.54e-07	0.00021	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	1.53e-07	0.000208	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—uterine cancer	1.51e-07	0.000206	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—STK11—uterine cancer	1.5e-07	0.000204	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.5e-07	0.000204	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—uterine cancer	1.49e-07	0.000202	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	1.48e-07	0.000201	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	1.47e-07	0.0002	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—uterine cancer	1.47e-07	0.0002	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	1.47e-07	0.0002	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	1.46e-07	0.000199	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	1.46e-07	0.000199	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MTHFR—uterine cancer	1.46e-07	0.000198	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	1.45e-07	0.000198	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRAS—uterine cancer	1.44e-07	0.000196	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EP300—uterine cancer	1.44e-07	0.000196	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	1.44e-07	0.000196	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	1.44e-07	0.000195	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	1.42e-07	0.000193	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EP300—uterine cancer	1.42e-07	0.000193	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—EP300—uterine cancer	1.4e-07	0.000191	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—uterine cancer	1.38e-07	0.000187	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	1.37e-07	0.000186	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	1.37e-07	0.000186	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	1.36e-07	0.000185	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	1.36e-07	0.000185	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRAS—uterine cancer	1.35e-07	0.000184	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—uterine cancer	1.35e-07	0.000183	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	1.34e-07	0.000183	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	1.33e-07	0.000181	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRAS—uterine cancer	1.33e-07	0.000181	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	1.32e-07	0.00018	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	1.32e-07	0.00018	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	1.29e-07	0.000175	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.28e-07	0.000175	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—EP300—uterine cancer	1.28e-07	0.000175	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—uterine cancer	1.28e-07	0.000174	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—uterine cancer	1.27e-07	0.000173	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	1.27e-07	0.000172	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EP300—uterine cancer	1.26e-07	0.000171	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	1.26e-07	0.000171	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—uterine cancer	1.24e-07	0.000169	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	1.23e-07	0.000167	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—uterine cancer	1.22e-07	0.000166	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—uterine cancer	1.22e-07	0.000166	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—EP300—uterine cancer	1.21e-07	0.000165	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	1.2e-07	0.000163	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	1.19e-07	0.000162	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	1.18e-07	0.00016	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EP300—uterine cancer	1.17e-07	0.000159	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—uterine cancer	1.17e-07	0.000159	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—uterine cancer	1.16e-07	0.000158	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—uterine cancer	1.14e-07	0.000155	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	1.14e-07	0.000155	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MTHFR—uterine cancer	1.13e-07	0.000153	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	1.11e-07	0.000151	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—uterine cancer	1.11e-07	0.00015	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	1.1e-07	0.000149	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	1.07e-07	0.000145	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—uterine cancer	1.06e-07	0.000144	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	1.05e-07	0.000143	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—uterine cancer	1.04e-07	0.000142	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—uterine cancer	1.04e-07	0.000141	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—uterine cancer	1.03e-07	0.000141	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—uterine cancer	1.03e-07	0.00014	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—uterine cancer	1.02e-07	0.000138	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—uterine cancer	1.02e-07	0.000138	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	1.02e-07	0.000138	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—uterine cancer	9.99e-08	0.000136	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—uterine cancer	9.87e-08	0.000134	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—uterine cancer	9.72e-08	0.000132	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—EP300—uterine cancer	9.69e-08	0.000132	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—uterine cancer	9.58e-08	0.00013	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—uterine cancer	9.5e-08	0.000129	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	9.44e-08	0.000128	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—uterine cancer	9.33e-08	0.000127	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	9.33e-08	0.000127	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—EP300—uterine cancer	9.13e-08	0.000124	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—uterine cancer	9.03e-08	0.000123	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—uterine cancer	8.98e-08	0.000122	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—uterine cancer	8.72e-08	0.000119	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	8.67e-08	0.000118	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	8.63e-08	0.000117	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—uterine cancer	8.58e-08	0.000117	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—uterine cancer	8.47e-08	0.000115	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—uterine cancer	8.39e-08	0.000114	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—uterine cancer	8.11e-08	0.00011	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	8.02e-08	0.000109	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—uterine cancer	7.76e-08	0.000106	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—EP300—uterine cancer	7.74e-08	0.000105	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	7.62e-08	0.000104	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—uterine cancer	7.33e-08	9.97e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—uterine cancer	7.17e-08	9.75e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	7.08e-08	9.63e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—uterine cancer	6.76e-08	9.19e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—uterine cancer	6.26e-08	8.51e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—EP300—uterine cancer	5.97e-08	8.12e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—uterine cancer	5.86e-08	7.96e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—uterine cancer	5.72e-08	7.78e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—uterine cancer	5.52e-08	7.5e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—uterine cancer	4.67e-08	6.36e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.42e-08	6.01e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—uterine cancer	3.61e-08	4.91e-05	CbGpPWpGaD
